These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26986027)

  • 1. Optimize and refine therapeutic index in radiation therapy: Overview of a century.
    Chargari C; Magne N; Guy JB; Rancoule C; Levy A; Goodman KA; Deutsch E
    Cancer Treat Rev; 2016 Apr; 45():58-67. PubMed ID: 26986027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Head and neck squamous cell carcinoma: optimizing the therapeutic index.
    Rosenthal DI; Blanco AI
    Expert Rev Anticancer Ther; 2005 Jun; 5(3):501-14. PubMed ID: 16001957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
    Corvò R
    Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoradiotherapy: emerging treatment improvement strategies.
    Milas L; Mason KA; Liao Z; Ang KK
    Head Neck; 2003 Feb; 25(2):152-67. PubMed ID: 12509799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered radiation therapy fractionation, chemoradiation, and patient selection for the treatment of head and neck squamous carcinoma.
    Rosenthal DI; Ang KK
    Semin Radiat Oncol; 2004 Apr; 14(2):153-66. PubMed ID: 15095261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient safety in external beam radiation therapy.
    Yorke E; Gelblum D; Ford E
    AJR Am J Roentgenol; 2011 Apr; 196(4):768-72. PubMed ID: 21427323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in Radiotherapy for Head and Neck Cancer.
    Grégoire V; Langendijk JA; Nuyts S
    J Clin Oncol; 2015 Oct; 33(29):3277-84. PubMed ID: 26351354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolution of the basic concepts underlying the practice of radiotherapy from 1949 to 1977.
    Fletcher GH
    Radiology; 1978 Apr; 127(1):3-19. PubMed ID: 345340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pulsed, spatially fractionated, microscopic synchrotron X-ray beams on normal and tumoral brain tissue.
    Bräuer-Krisch E; Serduc R; Siegbahn EA; Le Duc G; Prezado Y; Bravin A; Blattmann H; Laissue JA
    Mutat Res; 2010; 704(1-3):160-6. PubMed ID: 20034592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous beam geometry and intensity map optimization in intensity-modulated radiation therapy.
    Lee EK; Fox T; Crocker I
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):301-20. PubMed ID: 16289912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical development of molecularly targeted agents in combination with radiation therapy: a pharmaceutical perspective.
    Ataman OU; Sambrook SJ; Wilks C; Lloyd A; Taylor AE; Wedge SR
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e447-54. PubMed ID: 22819210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
    Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
    Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [How to enhance the efficacy of radiotherapy].
    Calais G
    Rev Prat; 1994 Apr; 44(8):1021-5. PubMed ID: 7939318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of failure following surgical resection for malignant pleural mesothelioma.
    Jänne PA; Baldini EH
    Thorac Surg Clin; 2004 Nov; 14(4):567-73. PubMed ID: 15559064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges of integrating chemotherapy and targeted therapy with radiation in locally advanced head and neck squamous cell cancer.
    Marur S; Forastiere AA
    Curr Opin Oncol; 2010 May; 22(3):206-11. PubMed ID: 20216313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward improving the therapeutic ratio in stereotactic radiosurgery: selective modulation of the radiation responses of both normal tissues and tumor.
    Hopewell JW; Millar WT; Ang KK
    J Neurosurg; 2007 Jul; 107(1):84-93. PubMed ID: 17639878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Normal tissue tolerance to external beam radiation therapy: bone marrow].
    Drouet F; Lagrange JL
    Cancer Radiother; 2010 Jul; 14(4-5):392-404. PubMed ID: 20598617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck.
    Budach W; Hehr T; Budach V; Belka C; Dietz K
    BMC Cancer; 2006 Jan; 6():28. PubMed ID: 16448551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of amifostine as a radioprotector.
    Wasserman TH; Brizel DM
    Oncology (Williston Park); 2001 Oct; 15(10):1349-54; discussion 1357-60. PubMed ID: 11702962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Keynote address: modulation of normal tissue toxicity by combined modality therapy: considerations for improving the therapeutic gain.
    Stewart FA
    Int J Radiat Oncol Biol Phys; 1991 Feb; 20(2):319-25. PubMed ID: 1991696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.